Navigation Links
Osteotech Reports 2008 Second Quarter Diluted Earnings Per Share of $.10 on Revenues of $27.6 Million
Date:7/31/2008

services, the impact of competitive products and services, the availability of sufficient quantities of suitable donated tissue and the success of cost control and margin improvement efforts. Certain of these factors are detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. All information in this press release is as of July 31, 2008 and the Company does not intend to update this information.

OSTEOTECH, INC. and Subsidiaries

CONSOLIDATED STATEMENTS OF OPERATIONS

(dollars in thousands, except per share data)

Three Months Six Months

Ended June 30, Ended June 30,

2008 2007 2008 2007

Revenue $27,553 $26,470 $55,184 $51,687

Cost of revenue 13,051 13,680 26,440 26,580

Gross profit 14,502 12,790 28,744 25,107

Marketing, selling and

general and

administrative expenses 11,323 10,434 23,003 22,124

Research and development

expenses 1,774 1,281 3,534 2,445

13,097 11,715 26,537 24,569

Operating income 1,405 1,075 2,207 538

Interest expense, net (274) (152) (486) (302)

Other 945 (114) 1,223 22

Income before income taxes 2,076 809 2,944 258

Income tax provision

(benefit) 330 (46) 390 51

Net Income $1,746 $855 $ 2,554 $207

Earnings per share:

Basic
'/>"/>

SOURCE Osteotech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
2. Osteotech Completes Tissue Supply Agreement With LifeNet Health
3. Osteotech Announces Third Quarter Earnings Release and Conference Call Schedule
4. Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09
5. Osteotech Signs Agreement To Distribute Harvest Technologies BMAC(TM) System
6. Osteotech Engages BioHorizons as Exclusive Distributor to International Dental Market
7. Osteotech Announces the Unexpected Passing of Audit Committee Member Leads to Receipt of Nasdaq Deficiency Letter
8. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
9. Haemacure Reports Third Quarter 2007 Results
10. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
11. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...CHICAGO, Nov. 28 Get ready for ...n the clinical routine when Siemens introduces...bly and Annual Meeting of the Radiological Society...ber 3 at McCormick Place (Booth #825, East Buildin...go. via , Siemens, new imaging software for m...
(Date:11/28/2009)...ne variation believed to affect circadian rhythm,...) -- New research suggests that an internal body c...he development of bipolar disorder in children. ,...e genetic makeup of 152 children with bipolar diso...ood swings, and 140 children without the disorder....
(Date:11/27/2009)...EDFORD, Mass., Nov. 27 G... a supplier of precision technology products and s...al meeting of the Company,s shareholders has been ...d location of the meeting will be announced in due...eived a requisition notice from Stephen Bershad, a...
(Date:11/27/2009)... Biotech firm Replikins Ltd. today issu...us genomic data. It shows that the lethality of t...5) during the virus,s current outbreak in the spri...k of 2.0 (s.d. 0.1). The H1N1 infectivity count, h... Boston (PRWEB) November 27, 2009 -- Biotech fi...
(Date:11/27/2009)... FRANCISCO, Nov. 27 The ...at Blair Lambert, CFO/COO, will present at the NAS...at the May Fair Hotel in London, England, on Wedne...o listen to a live broadcast of The Gymboree Corpo...g on to www.gymboree.com, click on "Our Company" a...
Breaking Medicine News(10 mins):Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:GSI Group Calls Shareholders Meeting 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5
...al Corporation,(OTC Bulletin Board: CONX), a world...s, reported sales of $2,001,896 for the first fisc... $2,105,188 for the quarter,ended September 30, 20... The first quarter of fiscal 2009 produced an oper...
...orts and,Nutritional Supplements developer and man...TNI) announced today that the company,s primary op...ional, Inc. (INII) has signed a,five year exclusiv...urdur Arnason. The contract calls for minimum,purc...
...utical Company,(NYSE: KVa ; KVb) announced that i...Commission a Form 12b-25 notification that its Qua...eptember 30, 2008 will be delayed., About KV Phar...ires,technology-distinguished branded and generic/...
...e the majority of employers believe the best way t...overhaul, they are confident that the U.S. should ...ystem. , Brookfield, Wisc...hey are confident that the U.S. should not move aw...
...cent innovation in laser skin treatments combines ...ent Dual Mode RF System uses unipolar and bipolar ...n both shallow and deep tissue depths. The technol...WEB) November 13, 2008 -- A new skin rejuvenation...
...uest Biosciences, Inc. a,development stage pain ma...d and Drug Administration (FDA) has accepted its I...-1015, its abuse deterrent extended release,strong...cer of TheraQuest stated,"Sustained release opioid...
Other Medicine News:Health News:Corgenix Reports Financial Results for First Quarter of Fiscal 2009 2Health News:Corgenix Reports Financial Results for First Quarter of Fiscal 2009 3Health News:Natural Nutrition Canadian Subsidiary Signs $50.5 Million (CDN) Five Year European Distribution Contract 2Health News:KV Pharmaceutical Company Files Form Reporting Delay in Filing Second Quarter Form 10-Q 2Health News:KV Pharmaceutical Company Files Form Reporting Delay in Filing Second Quarter Form 10-Q 3Health News:KV Pharmaceutical Company Files Form Reporting Delay in Filing Second Quarter Form 10-Q 4Health News:Employers Want National Approach to Health Care—Still Believe Employer-Based System Works Best: New Survey Looks At Attitudes toward Health Care Reform and Major Health Care Issues. 2Health News:Employers Want National Approach to Health Care—Still Believe Employer-Based System Works Best: New Survey Looks At Attitudes toward Health Care Reform and Major Health Care Issues. 3Health News:Accent Dual Mode Skin Tightening Laser is Latest Offering from Juva Skin Center 2Health News:TheraQuest's IND for Abuse Deterrent Strong Opioid (TQ-1015) Accepted by FDA 2
(Date:11/25/2009)..., , RANCHO CORDOVA, Calif., Nov. 25 /PRNews...ary of American Pacific Corporation (Nasdaq: APFC...tal Responsibility and Sustainability Award at the...by the California Manufacturers and Technology Ass...ciation (IEA) and the Chemical Industry Council of...
(Date:11/25/2009)..., , NEW YORK, Nov. 25 ...arch report is available in its catalogue: ,, ...ve ,, http://www.reportlinker.com/p0164330/M....html ,, Rising incidence of breast cancer in ...principal factor influencing growth in the mammogr...
(Date:11/25/2009)..., , SAN DIEGO, Nov. 25 /PRNewswire-...edical device company focused on developing produc...r the spine, announced today that it will host a c...30 p.m. ET / 2:30 p.m. PT. The conference call wi...nt for the Company,s products and will include com...
Breaking Medicine Technology:AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3NuVasive Announces Conference Call and Webcast Regarding Reimbursement 4Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference 14150 1Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference 14150 2Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference 14150 3Cheap quick bedside eye movement exam outperforms MRI for diagnosing stroke in patients 57673 1Cheap quick bedside eye movement exam outperforms MRI for diagnosing stroke in patients 57673 2Cheap quick bedside eye movement exam outperforms MRI for diagnosing stroke in patients 57673 3Guatemala Treatment Center Becomes First in Latin America to Introduce Fast and Precise RapidArc Radiotherapy Cancer Treatments 57669 1Guatemala Treatment Center Becomes First in Latin America to Introduce Fast and Precise RapidArc Radiotherapy Cancer Treatments 57669 2
...search reflects depth and breadth of, collaborati...atments for diverse forms o...f Zometa(R), the leading IV, bisphosphonate, on re...cer, - Four oral sessions to feature RAD001, firs...ncluding first results of RECORD-1 study in renal ...
...ith a newly cleared device to identify the, lipid...e associated with complications ...InfraReDx, Inc. today,announced that physicians at...ssfully used its LipiScan(TM) Coronary Imaging Sys...ion. This is the first patient in the,world in who...
Other Medicine Technology:Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 2Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 4Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 5Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 6Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 7Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 8Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 9Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 10First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4
...trade; RT cannulas are all able to be used with th...RT system. , ,The VERSAPORT™ RT cannulas ar...ms packaged for use with the RT system. The trocar...ade; Plus V2, SURGISPIKE™ (5mm only, no dila...
VERSAPORT™ Plus RT Single Use Obturators
SURGISPIKE™ Non-Shielded Single Use 5 mm Trocar
...e™ SPRING-GRIP™ single use nonconducti... 11 mm and 12 mm sizes for use with the SURGIPORT&... mm-11 mm, 5 mm-12 mm and 10 mm-15 mm sizes for us...EMIUM SURGIPORT™, SURGIPORT™ III and V...
Medicine Products: